Neuroimmunomodulation
Original Paper
Glutathione Homeostasis Disruption of Erythrocytes, but Not Glutathione Peroxidase Activity Change, Is Closely Accompanied with Neurological and Radiological Scoring of Acute CNS InflammationLjubisavljevic S.a, c · Stojanovic I.d · Cvetkovic T.d · Vojinovic S.a · Stojanov D.b · Stojanovic D.c · Bojanic V.c · Stokanovic D.e · Pavlovic D.daClinic of Neurology and bCenter for Radiology, Clinical Center Nis, and Institutes of cPathophysiology, dBiochemistry and ePharmacology, Faculty of Medicine, University of Nis, Nis, Serbia
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: June 19, 2013
Accepted: August 14, 2013
Published online: October 10, 2013
Issue release date: December 2013
Number of Print Pages: 8
Number of Figures: 2
Number of Tables: 4
ISSN: 1021-7401 (Print)
eISSN: 1423-0216 (Online)
For additional information: https://www.karger.com/NIM
Abstract
Objectives and Methods: The levels of glutathione (GSH) and glutathione peroxidase (GPx) activity were measured in the erythrocytes of 50 patients with clinically isolated syndrome of CNS (CIS) and 57 patients with relapsing remitting multiple sclerosis (RRMS). Results: A decrease in GSH content and GPx activity showed significance in both study groups compared to the control values (p = 0.0025 and 0.007 for GSH and p = 0.005 and 0.003 for GPx, in CIS and RRMS patients, respectively). The depletions were more pronounced in RRMS than in CIS patients (p = 0.009 for GSH and p = 0.031 for GPx). The results significantly verify the negative correlations between GSH values and clinical severity (r = -0.513, p = 0.004), radiological findings (r = -0.351, p = 0.008) and disease duration (r = -0.412, p = 0.0025) in CIS patients. The same correlations were observed in RRMS patients between GSH values and clinical severity (r = -0.498, p = 0.004) and patients' radiological features (r = -0.454, p = 0.005). No correlations were observed between GSH values and other patient characteristics, or between GPx activity and all tested patient characteristics (p > 0.01). Conclusions: The results indicate that GSH content and GPx activity both decreased below the normal range and were accompanied with neuroinflammation, but although both might have great importance in neuroinflammation development, the data presented here confirm that only GSH might serve as a marker which is closely correlated with neurological and radiological scoring of acute CNS inflammation.
© 2013 S. Karger AG, Basel
Related Articles:
References
- Barnham KL, Masters CL, Bush AI: Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 2004;3:205-214.
- Floyd RA, Hensley K: Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol Aging 2002;23:795-807.
- Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A: Biomarkers of oxidative damage in human disease. Clin Chem 2006;52:601-623.
- Staron A, Makosa G, Koter-Michalak M: Oxidative stress in erythrocytes from patients with rheumatoid arthritis. Rheumatol Int 2012;32:331-334.
- Deneke SM: Thiol-based antioxidants. Curr Top Cell Regul 2000;36:151-180.
-
Brack M, Brack O, Ménézo Y, Bonnefont Rousselot D, Dreyfus G, John Chapman M, Kontush A: Distinct profiles of systemic biomarkers of oxidative stress in chronic human pathologies: cardiovascular, psychiatric, neurodegenerative, rheumatic, infectious, neoplasmic and endocrinological diseases. Adv Biosci Biotechnol 2013;4:331-339.
- Ljubisavljevic S, Stojanovic I, Vojinovic S, Stojanov D, Stojanovic S, Cvetkovic T, Savic D, Pavlovic D: The patients with clinically isolated syndrome and relapsing remitting multiples sclerosis show different levels of advanced protein oxidation products and reduced thiols content in sera and CSF. Neurochem Int 2013;62:988-997.
- Ljubisavljevic S, Stojanovic I, Vojinovic S, Stojanov D, Stojanovic S, Kocic G, Savic D, Cvetkovic T, Pavlovic D: Cerebrospinal fluid and plasma oxidative stress biomarkers in different clinical phenotypes of neuroinflammatory acute attacks. Conceptual accession: from fundamental to clinic. Cell Mol Neurobiol 2013;33:767-777.
- Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS: Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292-302.
- Lublin FD, Reingold SC: Defining the clinical course of multiple sclerosis: results of an international survey - National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46:907-911.
- Kurtzke JF: Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983;33:1444-1452.
- Drabkin DL: The crystallographic and optical properties of the haemoglobin of man in comparison with those of other species. J Biol Chem 1946;164:703-723.
- Ellman G: Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-77.
- Paglia DE, Valentine WN: Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. Lab Clin Med 1967;70:158-169.
- Grinberg L, Fibach E, Amer J, Atlas D: N-acetylcysteine amide, a novel cell-permeating thiol, restores cellular glutathione and protects human red blood cells from oxidative stress. Free Radic Biol Med 2005;38:1136-1145.
- Calabrese V, Scapagnini G, Ravagna A, Bella R, Foresti R, Bates TE, Giuffrida Stella AM, Pennisi G: Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels. J Neurosci Res 2002;70:580-587.
- Kidd PM: Multiple sclerosis, an autoimmune inflammatory disease: prospects for its integrative management. Altern Med Rev 2001;6:540-566.
- Ljubisavljevic S, Stojanovic I, Pavlovic R, Stojnev S, Stevanovic I, Sokolovic D, Pavlovic D: The reduced glutathione and S-nitrosothiol levels in acute phase of experimental demyelination - pathophysiological approach and possible clinical relevancy. Neuroscience 2012;219:175-182.
- Tchantchou F, Graves M, Ortiz D, Rogers E, Shea TB: Dietary supplementation with apple juice concentrate alleviates the compensatory increase in glutathione synthase transcription and activity that accompanies dietary and genetically induced oxidative stress. J Nutr Health Aging 2004;8:492-496.
- Besler HT, Comoglu S, Okcu Z: Serum levels of antioxidant vitamins and lipid peroxidation in multiple sclerosis. Nutr Neurosci 2002;5:215-220.
- Rahman I, MacNee W: Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radic Biol Med 2000;28:1405-1420.
- Rahman I: Inflammation and the regulation of glutathione level in lung epithelial cells. Antioxid Redox Signal 1999;1:425-447.
- Pan Z, Perez-Polo R: Role of nerve growth factor in oxidant homeostasis: glutathione metabolism. J Neurochem 1993;61:1713-1721.
- Calabrese V, Bella R, Testa D, Spadaro F, Scrofani A, Rizza V, Pennisi G: Increased cerebrospinal fluid and plasma levels of ultraweak chemiluminescence are associated with changes in the thiol pool and lipid-soluble fluorescence in multiple sclerosis: the pathogenic role of oxidative stress. Drugs Exp Clin Res 1998;24:125-131.
- Hvaring C, Vujicic S, Aasly JO, Feinstein DL, White LR, Boullerne AI: IgM to S-nitrosylated protein is found intrathecally in relapsing-remitting multiple sclerosis. J Neuroimmunol 2013;256:77-83.
- van Meeteren ME, Teunissen CE, Dijkstra CD, van Tol EAF: Antioxidants and polyunsaturated fatty acids in multiple sclerosis. Eur J Clin Nutr 2005;59:1347-1361.
- Tasset I, Agüera E, Sánchez-López F, Feijóo M, Giraldo AI, Cruz AH, Gascón F, Túnez I: Peripheral oxidative stress in relapsing-remitting multiple sclerosis. Clin Biochem 2012;45:440-444.
- Lin SX, Lisi L, Dello Russo C, Polak PE, Sharp A, Weinberg G, Kalinin S, Feinstein DL: The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and haem oxygenase-1. ASN Neuro 2011;3:e00055.
- Adamczyksowa M, Sowa P, Pierzchala K, Polaniak R, Labuzroszak B: Antioxidative enzyme activity and malondialdehyde concentration during mitoxantrone therapy in multiple sclerosis patients. J Physiol Pharmacol 2012;63:683-690.
- Miller E, Mrowicka M, Zołyński K, Kedziora J: Oxidative stress in multiple sclerosis. Pol Merkur Lekarski 2009;162:499-502.
- Nath N, Morinaga O, Singh I: S-nitrosoglutathione, a physiologic nitric oxide carrier, attenuates experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol 2010;2:240-251.
- Straif D, Werz DO, Kellner R, Bahr U, Steinhilber D: Glutathione peroxidase-1 but not -4 is involved in the regulation of cellular 5-lipoxygenase activity in monocytic cells. Biochem J 2000;349:455-461.
- Forgione MA, Weiss N, Heydrick S, Cap A, Klings ES, Bierl C, Eberhardt RT, Farber HW, Loscalzo J: Cellular glutathione peroxidase deficiency and endothelial dysfunction. Am J Physiol Heart Circ Physiol 2002;282:H1255-H1261.
Article / Publication Details
Received: June 19, 2013
Accepted: August 14, 2013
Published online: October 10, 2013
Issue release date: December 2013
Number of Print Pages: 8
Number of Figures: 2
Number of Tables: 4
ISSN: 1021-7401 (Print)
eISSN: 1423-0216 (Online)
For additional information: https://www.karger.com/NIM
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
